SEMA3A and neoplasm: Others have indeed shown that anti-NRP1 antibodies can affect tumor growth in mouse models19,62,69, likely by both inhibiting Treg cells and, as we show here, by decreasing the effects of SEMA3A on CD8+ effector T cells.